Spotlight Session– BACH1 Inhibitor as Therapeutics for Sickle Cell Disease

Time: 9:30 am
day: Day One


  • Developing therapeutics modulating mitochondrial function to address various diseases
  • Developing a BACH1 inhibitor that can regulate antioxidant response genes through Nrf2 pathway
  • Reviewing the preclinical data supporting the therapeutic efficacy of BACH1 inhibitor to treat sickle cell disease